- Trials with a EudraCT protocol (25)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
25 result(s) found for: Corifollitropin alfa.
Displaying page 1 of 2.
EudraCT Number: 2006-003812-23 | Sponsor Protocol Number: 107014 | Start Date*: 2006-12-21 |
Sponsor Name:NV Organon | ||
Full Title: Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 107012 for the development of Org 36286 (corifollitropin alfa) | ||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) AT (Completed) CZ (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003811-36 | Sponsor Protocol Number: 107012 | Start Date*: 2007-01-03 |
Sponsor Name:NV Organon | ||
Full Title: A phase III, randomized, double-blind, active-controlled, equivalence clinical trial to investigate the efficacy and safety of a single injection of 100 µg Org 36286 (corifollitropin alfa) to induc... | ||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) AT (Completed) DK (Completed) CZ (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000583-29 | Sponsor Protocol Number: 143201316398 | Start Date*: 2013-04-08 |
Sponsor Name:Universitair Ziekenhuis Brussel | ||
Full Title: Corifollitropin alfa followed by hp-HMG versus recombinant FSH in young poor ovarian responders. A multicentre randomized controlled clinical trial | ||
Medical condition: Infertility in women with poor ovarian response to stimulation for IVF/ICSI | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002979-17 | Sponsor Protocol Number: MANCOR | Start Date*: 2014-01-27 |
Sponsor Name:IVI Sevilla | ||
Full Title: Comparative study between the usage of corifollitropin alfa and daily recombinant FSH in the ovarian stimulation of low responders | ||
Medical condition: Low response to ovarian stimulation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-003813-42 | Sponsor Protocol Number: 107015 | Start Date*: 2006-12-21 |
Sponsor Name:NV Organon | ||
Full Title: Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 107012 | ||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) AT (Completed) CZ (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001835-22 | Sponsor Protocol Number: MONACO | Start Date*: 2021-10-20 |
Sponsor Name:Ghent University Hospital | ||
Full Title: A randomized comparison of one controlled ovarian stimulation with corifollitropin alfa (CFA) versus up to three modified natural cycles (MNC) in expected and established poor responders | ||
Medical condition: this study will compare the efficacy of two different strategies for the management of predicted low prognosis patients under stimulation for IVF/ICSI: up to three MNCs (Modified Natural Cycle) (c... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001258-25 | Sponsor Protocol Number: MK8962-031-00 | Start Date*: 2012-11-29 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A phase III, multi-center, open label, uncontrolled trial to investigate the efficacy and safety of MK-8962 (corifollitropin alfa) in combination with human Chorionic Gonadotropin (hCG) in inducing... | |||||||||||||
Medical condition: Hypogonadotropic hypogonadism (HH) in males may result from either absent or inadequate gonadotropin-releasing hormone (GnRH) secretion by the hypothalamus or failure of pituitary gonadotropin secr... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) IT (Completed) GB (Completed) PL (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004967-30 | Sponsor Protocol Number: 38829 | Start Date*: 2006-11-01 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 38825 for Org 36286 (corifollitropin alfa) | |||||||||||||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) FR (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002000-13 | Sponsor Protocol Number: rFSHdosingfinding.2018 | Start Date*: 2019-01-09 | |||||||||||
Sponsor Name:University hospital Brussel | |||||||||||||
Full Title: Effect of recombinant FSH dosing following corifollitropin alfa in patients undergoing IVF/ICSI in a GnRH antagonist protocol: a randomized controlled dose-finding study. | |||||||||||||
Medical condition: Subfertility in need of IVF and IVF-ICSI treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003484-56 | Sponsor Protocol Number: BOLDOS-18 | Start Date*: 2019-12-26 | |||||||||||
Sponsor Name:Miguel Caballero Campo | |||||||||||||
Full Title: Efficacy of corifolitropin alfa in double ovarian stimulation compared with two conventional ovarian stimulation cycles for embryo accmulation in low responder patients. Multicenter randomized cont... | |||||||||||||
Medical condition: Infertility in patients requiring in vitro fertilization treatment with poor ovarian response profile, defined by Bologna Criteria. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001343-44 | Sponsor Protocol Number: IB-0319-002 | Start Date*: 2019-05-21 |
Sponsor Name:Instituto Bernabeu | ||
Full Title: Conventional ovarian stimulation vs. stimulation with single injection of Corifollitropin alfa in oocyte donors. Randomized clinical trial. Tail Studio | ||
Medical condition: Oocyte donation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002027-42 | Sponsor Protocol Number: POR-ELONVA | Start Date*: 2013-08-14 |
Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | ||
Full Title: PROSPECTIVE AND RANDOMIZED STUDY FOR ASSESSMENT OF CONTROLLED OVARIAN STIMULATION WITH ALFA Corifollitropin IN PATIENTS WITH OVARIAN RESPONSE EXPECTED OR POOR IN VITRO FERTILIZATION CYCLE. | ||
Medical condition: Women who meet the criteria for infertility Bologna | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001743-20 | Sponsor Protocol Number: 1403-MAD-013-AR | Start Date*: 2015-07-30 |
Sponsor Name:IVI Madrid | ||
Full Title: A Multicentre, prospective, randomised clinical trial comparing the cost and efficacy of corifolitropina alfa vs Recombinant FSH and / or HP-hMG | ||
Medical condition: The study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation program | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004772-36 | Sponsor Protocol Number: 38821 | Start Date*: 2006-06-30 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: Pregnancy and neonatal follow-up of ongoing pregnancies established after controlled ovarian stimulation in clinical trial 38819 for Org 36286 (corifollitropin alfa) | |||||||||||||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) GB (Completed) SE (Completed) ES (Completed) BE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004771-11 | Sponsor Protocol Number: 38819 | Start Date*: 2006-06-30 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: A phase III, randomized, double-blind, active-controlled, non-inferiority clinical trial to investigate the efficacy and safety of a single injection of Org 36286 (corifollitropin alfa) to induce m... | |||||||||||||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) NL (Completed) GB (Completed) SE (Completed) DK (Completed) ES (Completed) BE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005145-23 | Sponsor Protocol Number: 53736 | Start Date*: 2017-08-29 | |||||||||||||||||||||
Sponsor Name:DIPARTIMENTO DI SCIENZE CHIRURGICHE - UNIVERSITà DEGLI STUDI DI TORINO | |||||||||||||||||||||||
Full Title: Prospective randomized trial comparing corifollitropin alfa (CF-alfa) late start (day 4) vs. CF-alfa standard start (day2) in poor, normal and potential high-responders undergoing IVF/ICSI | |||||||||||||||||||||||
Medical condition: Women with low reproductive capacity | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004773-28 | Sponsor Protocol Number: 38831 | Start Date*: 2006-06-30 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: Follow-up protocol to collect the outcome of frozen-thawed embryo transfer cycles after cryopreservation of embryos in clinical trial 38819 | |||||||||||||
Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) GB (Completed) SE (Completed) ES (Completed) BE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001878-18 | Sponsor Protocol Number: MK8962-043 | Start Date*: 2017-07-19 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase III, Multi-Center, Open Label, Single-Group Trial to Investigate the Efficacy and Safety of MK-8962 (corifollitropin alfa) in Combination with human Chorionic Gonadotropin (hCG) for Initiat... | |||||||||||||
Medical condition: Treatment of adolescent males 14 to <18 years old with HH | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) DK (Prematurely Ended) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001342-18 | Sponsor Protocol Number: IB-0319-001 | Start Date*: 2019-08-19 |
Sponsor Name:Instituto Bernabeu | ||
Full Title: CONVENTIONAL STIMULATION IN FOLICULAR PHASE VS. STIMULATION IN LUTEA PHASE IN PATIENTS WITH SUBOPTIMA RESPONSE. RANDOMIZED CLINICAL TRIAL. SUBLUTEAL STUDY | ||
Medical condition: Suboptimal response of ovarian stimulation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000971-17 | Sponsor Protocol Number: 58335 | Start Date*: 2019-07-17 |
Sponsor Name:UZ Brussel | ||
Full Title: Double trigger and ovum retrieval vs. conventional antagonist ovarian stimulation protocol in poor prognosis women undergoing IVF/ICSI: A pilot study | ||
Medical condition: infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
